Results

eNauka >  Results >  Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON)
Title: Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON)
Authors Tobias, Joshua; ...; Andric, Zoran G  ; Petrovic, Z; Nikolic, Ivan V  ; ...; (broj, koautora 17)
Issue Date: 2024
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 35 br. Suppl 2 str. S886-S886
DOI: 10.1016/j.annonc.2024.08.1487
WoS-ID: 001326612902043
URI: https://enauka.gov.rs/handle/123456789/974845
Metadata source: (Preuzeto iz Nasi u WoS)
Note: ESMO Congress 2024, 13-17 September 2024
M-category: 
Mp. category will be shown later

Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.